Paxman
49.40 SEK
+1.65 %
Less than 1K followers
PAX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Paxman
P/E
Median 2019-2025
EV/S
Median 2019-2021
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 60.00 | 25.40 | 65.00 | 43.10 | 36.80 | 65.60 | 56.20 |
| Shares | 16.0 | 16.0 | 16.0 | 19.0 | 19.0 | 19.0 | 23.3 |
| Market cap | 960.8 | 406.7 | 1,040.8 | 819.4 | 699.7 | 1,247.2 | 1,308.0 |
| Enterprise value | 990.6 | 451.4 | 985.7 | - | - | - | - |
| EV/S | 11.6 | 5.8 | 10.2 | - | - | - | - |
| EV/EBITDA | 139.4 | neg. | 342.0 | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | 348.6 | neg. | neg. | neg. | 83.6 | 31.1 | neg. |
| P/B | 33.88 | 37.35 | 8.28 | 7.18 | 5.71 | 7.61 | 3.23 |
| P/S | 11.3 | 5.2 | 10.8 | 5.6 | 3.3 | 4.9 | 4.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 33.4 % | 14.1 % | 75.6 % | 65.6 % | 73.4 % | 72.2 % | 84.6 % |
| Gearing ratio | 110.9 % | 442.9 % | 13.6 % | 14.9 % | 11.1 % | 8.7 % | 3.2 % |